Stocks and Investing
Stocks and Investing
Wed, January 20, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, January 19, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $352 on, Jan 19th, 2021
Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $357 to $352 on, Jan 19th, 2021.
Matthew has made no other calls on BIIB in the last 4 months.
There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 6 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $249 on, Thursday, November 19th, 2020
- Phil Nadeau of "Cowen & Co." Downgraded from Buy to Hold and Held Target at $215 on, Monday, November 9th, 2020
- Colin Bristow of "UBS" Initiated at Hold and Held Target at $268 on, Wednesday, October 28th, 2020
- Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $282 on, Tuesday, October 27th, 2020
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $244 on, Thursday, October 22nd, 2020
- Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $265 on, Tuesday, October 20th, 2020
These are the ratings of the 5 analyists that currently disagree with Matthew
- Geoff Meacham of "B of A Securities" Downgraded from Hold to Sell and Held Target at $240 on, Monday, November 9th, 2020
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $382 on, Monday, November 9th, 2020
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $289 on, Monday, November 9th, 2020
- Steve Chesney of "Atlantic Equities" Downgraded from Hold to Sell and Held Target at $175 on, Monday, November 9th, 2020
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $350 on, Thursday, October 22nd, 2020
Contributing Sources